The focus of this meeting will be case studies of successful routes of synthesis for drug substance/API. But the overarching theme will be how process chemists deal with the challenge of ‘fit for purpose’ process R&D. Can you have a process that is workable for early phase or pre-clinical supply demands that have short timelines while at the same time planning for more long term development strategies? Click here to view a list of past Process Chemistry participants
Session Include:
- Case Studies of API Scale-up: Part I
- Chemistry through CROs
- Process Improvements
- Breakout Roundtable Discussions
- Clean and Green via Strategic Route Design
- Biocatalysis, Continuous Processing and Case Studies: Part II
Keynote Speaker
Michael J. Krische, Ph.D., Chair, Department of Chemistry and Biochemistry and Director, Center for Green Chemistry and Catalysis, University of Texas at Austin
Pre-conference Short Course*
June 1, 2011
Development of APIs — Efficiencies for a New Decade
Course Instructor: Neal G. Anderson, Principal, Anderson’s Process Solutions
*Separate registration required
Featured Speakers
Scott M. Duncan, Ph.D., Senior Manager, API Development & Process Chemistry, Alkermes, Inc.
Mahavir Prashad, Ph.D., Head of Chemical Development Unit US. Novartis Pharmaceuticals Corporation
Bruce Ross, Ph.D., Director, Process Research, Pharmasset
Matthew Truppo, Ph.D., Senior Scientist, Process Chemistry, Merck
Who should attend:
- Scientists, Chemists, and Chemical Engineers working in departments related to drug substance process development such as:
- Chemistry Process R&D
- Chemical Development
- Chemical Process Development
- Pharmaceutical Develompent
- Pharmaeutical Chemical Engineering
- Process Research
- Process Chemistry
- Process R&D